Palindrome
Payments companies reported to CMS as associated with Palindrome. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Palindrome, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Palindrome
These are the largest totals companies reported as associated with Palindrome. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Tal | New Haven, CT | Vascular & Interventional Radiology | $3,026,408.03 |
| Walter Nichols | Columbia, MO | Vascular Surgery | $11,349.17 |
| Prabir Roy Chaudhury | Cincinnati, OH | Nephrology (Internal Medicine) | $6,125.19 |
| John Vanstone | Columbia, MO | Nephrology (Internal Medicine) | $5,666.12 |
| Satyaki Banerjee | Albuquerque, NM | Nephrology (Internal Medicine) | $5,356.20 |
| Rishi Razdan | Jacksonville, FL | Vascular & Interventional Radiology | $922.93 |
| Stephen Hohmann | Dallas, TX | Vascular Surgery | $900.00 |
| Dirk Hentschel | Boston, MA | Nephrology (Internal Medicine) | $840.43 |
| Martin Schreiber | Cleveland, OH | Nephrology (Internal Medicine) | $750.24 |
| Amer Naiem | Pembroke Pines, FL | Vascular & Interventional Radiology | $265.86 |
Prescribed Palindrome?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.